Vascular and Nerve-Associated Inflammation in Lipedema Hand and Foot Tissue: A Case Report

Read full text
Authors: V. R. Bailey, Karen Louise Herbst, Allison O. Scott, Rachelle L. Crescenzi, Scott Thomas Hollenbeck, Sara Al-Ghadban
Cited by: 1

Abstract

Introduction: Lipedema is a chronic, progressive, and painful connective tissue disorder primarily affecting women.Symptoms include pain, limb heaviness, tenderness, easy bruising, and reduced mobility.Histologically, lipedema adipose tissue shows vascular dilation, adipocyte hypertrophy, and immune infiltration by macrophages and mast cells.Pain is thought to arise from heightened dermal sensitivity and neuropathic mechanisms.This study examines nerve-associated inflammation in lipedema, which has not been previously characterized.Methods: Skin and subcutaneous adipose tissue (5-μm sections) were collected from one patient (hand, foot, back), fixed in formaldehyde, and stained for inflammatory markers (CD68, CD163) and endothelial cells (CD31).H&E and Masson's trichrome staining were performed.Images were captured and manually quantified.Results: Cutaneous tissue from the hands and feet demonstrated increased microvascular density (CD31) with thickened walls, perivascular fibrosis, and macrophage infiltration (CD68, CD163).Macrophages were observed along the nerve fibers and outer nerve layers, consistent with localized nerve inflammation alongside vascular remodeling.Conclusion: This study demonstrates concurrent vascular remodeling and nerve-associated inflammation in lipedema adipose tissue of the hand and feet.These findings highlight that pain in lipedema involves both vascular and neurogenic inflammatory mechanisms, extending the understanding of lipedema pathology beyond the lower extremities.

Fields of Study & Subjects

Lymphatic System and Diseases Hypertrophic osteoarthropathy and related conditions Systemic Sclerosis and Related Diseases

Publication details

Journal / source
Annals of Case Reports
Publisher
Gavin Publishers
Volume
11
Issue
2
Publication date
6 April 2026